Open AccessMyeloablative chemotherapy in testicular cancer patient
Author(s) -
Karolina Furgała,
Zuzanna Smuniewska,
Dawid Sigorski,
Maciej Michalak,
Lubomir Bodnar
Publication year - 2021
Publication title -
oncoreview
Language(s) - English
Resource type - Journals
eISSN - 2450-6125
pISSN - 2353-852X
DOI - 10.24292/01.or.121030321
Subject(s) - medicine , chemotherapy , testicular cancer , hematopoietic stem cell transplantation , oncology , seminoma , surgery , salvage therapy , stem cell , transplantation , cancer , biology , genetics
Chemotherapy is the standard treatment for metastatic testicular cancers. The autologous hematopoietic stem cell transplantation is a salvage option for relapsed patients. The paper presents a case of a 20-year-old patient with stage IIIC non-seminoma treated with BEP chemotherapy and autologous transplantation of stem cells, which allowed to achieve durable remission.